Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment

• Status: Completed
• Trial end date: 2021-08-24
• Target enrollment: 0
• Participant gender: All

Summary

Suprachoroidal injection, a novel technique for delivering ocular therapies, may facilitate targeted therapeutic delivery to the choroidal and retinal structures than intravitreal injection

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Benha University
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• patients diagnosed as VKH serous retinal detachment in the acute phase whom BCVA is not improving after 2 weeks from starting systemic steroids.

Exclusion Criteria:

• recent intraocular surgery.

• patients refuse to participate in the study.

• media opacity and other causes of serous retinal detachment than VKH.